About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?

NCT02787187·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ruijin Hospital

With

Shanghai Zhongshan Hospital
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Pathologic diagnosis of pancreatic ductal adenocarcinoma
Signed the informed consents

You may not be if

Pathologic diagnosis of other pancreatic cancers
Pre-operative anti-cancer treatment
Recurrence patients
Patients with contraindication(hepatic/ respiratory/ renal dysfunction, etc )
Pre operative exam: Total bilirubin more than 250µmol/L
AJCC stage IV
Operation non radical

The record

StatusCompleted

PhaseNo phase

Taking part230

StartedJul 2016

UpdatedNov 23, 2021

Conditions

Pancreatic Ductal Adenocarcinoma

Where1

Shanghai Ruijin Hospital
Shanghai, Shanghai Municipality, China

Clareo Health | Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?